|
|
|
Sunday, March 8, 2009 — 1:30 Convention Center Auditorium
|
- An Update on Inflammatory Bowel Disease
|
|
Moderator:
|
Alyssa M. Krasinskas, University of Pittsburgh, Pittsburgh, PA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | Atypical Features of Ulcerative Colitis - Robert Odze, Brigham and Women's Hospital, Boston, MA |
| 2:00 | Pouchitis - Robert Riddell, Mount Sinai, Toronto, Canada |
| 2:30 | Malignancies in Inflammatory Bowel Disease - Noam Harpaz, Mount Sinai, New York, NY |
| 3:00 | Break |
| 3:30 | Molecular Pathogenesis of Neoplasia in Inflammatory Bowel Disease - Mary Bronner, Cleveland Clinic, Cleveland, OH |
| 4:00 | Rodger C. Haggitt Memorial Lecture:
Inflammatory Bowel Disease Dysplasia and its Management - Francis Farraye, Boston University, Boston, MA |
|
This topic was chosen based on recent advances in the field of inflammatory bowel disease; it is a topic that has not been covered in depth in this format. The symposium will cover issues ranging from diagnostic challenges in the bowel and the pouch to malignancies and the molecular pathogenesis of IBD neoplasia. The keynote speaker is a clinical gastroenterologist who will present new developments in the diagnosis and management of dysplasia in IBD. Members of the Education Committee were involved in the selection of the topics and speakers.
|
|
|
|
